For the Inventor, By the Inventor

Enter assignee name

Risen (Suzhou) Pharma Tech Co., Ltd.

USPTO Granted Patents = 16

Forward Citations = 11

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Jiasheng Lu (16 out of 16 patents)

Jiamin Gu (16 out of 16 patents)

Xianqi Kong (15 out of 38 patents)

4. Xiang Ji (11 out of 11 patents)

5. Daiqiang Hu (8 out of 8 patents)

6. Gang Chen (7 out of 7 patents)

7. Xinyong Lv (7 out of 7 patents)

8. Dongdong Wu (7 out of 9 patents)

9. Xiuchun Zhang (7 out of 7 patents)

10. Jinchao Ai (5 out of 5 patents)

11. Dongqing Zhu (5 out of 5 patents)

12. Xiaolin He (5 out of 5 patents)

13. Lin Wang (5 out of 30 patents)

14. Feng Zhou (4 out of 4 patents)

15. Guowei Song (3 out of 3 patents)

16 patents: Sort by Forward Citations

1. 12459888 - Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof (2025-11-04),

2. 12403129 - Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular disease (2025-09-02),

3. 12365675 - Stable heavy isotopes in amide functional groups and uses thereof (2025-07-22),

4. 12338205 - Crystalline form of 3-((L-valyl) amino)-1-propanesulfonic acid (2025-06-24),

5. 12312378 - Glucosamine derivatives for the prevention or treatment of joint disorders (2025-05-27),

6. 11970490 - Stable heavy isotopes in amide functional groups and uses thereof (2024-04-30),

7. 11725020 - Prodrugs of a CDK inhibitor for treating cancers (2023-08-15),

8. 11718636 - Glucosamine derivatives for the prevention or treatment of joint disorders (2023-08-08),

9. 11608314 - Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof (2023-03-21),

10. 11591358 - Glucosamine derivatives and pharmaceutical uses thereof (2023-02-28),

11. 11530234 - CD73 inhibitors and pharmaceutical uses thereof (2022-12-20),

12. 11225497 - Prodrugs of a CDK inhibitor for treating cancers (2022-01-18),

13. 11186543 - Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof (2021-11-30),

14. 10954188 - Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof (2021-03-23),

15. 10881681 - CD73 inhibitors and pharmaceutical uses thereof (2021-01-05),

Risen (Suzhou) Pharma Tech Co., Ltd. is a leading pharmaceutical company headquartered in Suzhou, China. With a focus on research and development, manufacturing, and distribution of high-quality pharmaceutical products, Risen Pharma Tech is committed to improving global healthcare standards. The company offers a wide range of innovative solutions for various therapeutic areas, including oncology, cardiovascular, and respiratory diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#34 in Suzhou

#1,607 in China

#36,671 in the World

Risen (Suzhou) Pharma Tech Co., Ltd.

Forward Citations = 11

23 inventors:

Jiasheng Lu (16 out of 16 patents)

Jiamin Gu (16 out of 16 patents)

Xianqi Kong (15 out of 38 patents)

4. Xiang Ji (11 out of 11 patents)

5. Daiqiang Hu (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…